Dialysis dose and risk factors for death among ESRD patients treated with twice-weekly hemodialysis: A prospective cohort study

Blood Purification

Volumn 38, Issue 3-4, 2014, Pages 253-262

  Panaput, Thanachai ^a   Thinkhamrop, Bandit ^a   Domrongkitchaiporn, Somnuek ^b   Sirivongs, Dhavee ^a   Praderm, Laksamon ^d   Anukulanantachai, Jirasak ^c   Kanokkantapong, Chavasak ^e   Tungkasereerak, Pakorn ^f   Pongskul, Cholatip ^a   Anutrakulchai, Sirirat ^a   Keobounma, Thathsalang ^g   Narenpitak, Surapong ⁱ   Intarawongchot, Pisith ^h   Suwattanasin, Ammrit ^j   Tatiyanupanwong, Sajja ^k   Niwattayakul, Kannika ^l  

^a KHON KAEN UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c KHON KAEN HOSPITAL   (Thailand)

^d Roi Et Hospital   (Thailand)

^e MAHARAT NAKHON RATCHASIMA HOSPITAL   (Thailand)

^f Surin Hospital   (Thailand)

^g Thabo Crown Prince Hospital   (Thailand)

^h Nongkhai Hospital   (Thailand)

ⁱ Udon Thani Center Hospital   (Thailand)

^j Mahasarakham Rajabhat University   (Thailand)

^k Chaiyapoom Hospital   (Thailand)

^l Muang Loei Ram Hospital   (Thailand)

more..

Author keywords

Adequacy; Hemodialysis; Prognostic factors; spKt V; Twice weekly dialysis

Indexed keywords

ALBUMIN; BICARBONATE; CALCIUM PHOSPHATE; FERRITIN; HEMOGLOBIN; HEPATITIS B ANTIGEN; HEPATITIS C ANTIBODY; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PARATHYROID HORMONE; TRIACYLGLYCEROL; SERUM ALBUMIN;

ADULT; AGE DISTRIBUTION; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; ASSESSMENT OF HUMANS; BICARBONATE BLOOD LEVEL; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; DEATH; END STAGE RENAL DISEASE; FEMALE; FERRITIN BLOOD LEVEL; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYPOALBUMINEMIA; INDEX OF COEXISTENT DISEASE; INFECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PARATHYROID HORMONE BLOOD LEVEL; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SMOKING; SURVIVAL RATE; TRIACYLGLYCEROL BLOOD LEVEL; ADOLESCENT; ADVERSE EFFECTS; AGE; CARDIOVASCULAR DISEASES; CLINICAL TRIAL; COMORBIDITY; DIABETES COMPLICATIONS; HEPATITIS, VIRAL, HUMAN; KAPLAN MEIER METHOD; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; PROCEDURES; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RENAL REPLACEMENT THERAPY; STATISTICS AND NUMERICAL DATA; THAILAND; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; COMORBIDITY; DIABETES COMPLICATIONS; FEMALE; HEPATITIS, VIRAL, HUMAN; HOSPITALIZATION; HUMANS; HYPOALBUMINEMIA; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RENAL DIALYSIS; RISK FACTORS; SERUM ALBUMIN; SMOKING; THAILAND; YOUNG ADULT;

EID: 84929654830     PISSN: 02535068     EISSN: 14219735     Source Type: Journal    
DOI: 10.1159/000368885     Document Type: Article

References (27)

1. Hemodialysis Adequacy 2006 Work Group: Clinical practice guidelines for hemodialysis adequacy, update 2006. Am J Kidney Dis 2006; 48(suppl 1):S2-S90.
2. Port FK, Wolfe RA, Hulbert-Shearon TE, Mc-Cullough KP, Ashby VB, Held PJ. High dialysis dose is associated with lower mortality among women but not among men. Am J Kidney Dis 2004; 43: 1014-1023.
3. Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 2002; 347: 2010-2019.
4. Termorshuizen F, Dekker FW, van Manen JG, Korevaar JC, Boeschoten EW, Krediet RT. Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. J Am Soc Nephrol 2004; 15: 1061-1070.
5. Couchoud C, Kooman J, Finne P, Leivestad T, Stojceva-Taneva O, Ponikvar JB, et al. From registry data collection to international comparisons: examples of haemodialysis duration and frequency. Nephrol Dial Transplant 2009; 24: 217-224.
6. Hanson JA, Hulbert-Shearon TE, Ojo AO, Port FK, Wolfe RA, Agodoa LY, et al. Prescription of twice-weekly hemodialysis in the USA. Am J Nephrol 1999; 19: 625-633.
7. Athienites NV, Miskulin DC, Fernandez G, Bunnapradist S, Simon G, Landa M, et al. Comorbidity assessment in hemodialysis and peritoneal dialysis using the index of coexistent disease. Semin Dial 2000; 13: 320-326.
8. Miskulin DC, Martin AA, Brown R, Fink NE, Coresh J, Powe NR, et al. Predicting 1 year mortality in an outpatient haemodialysis population: a comparison of comorbidity instruments. Nephrol Dial Transplant 2004; 19: 413-420.
9. Miskulin DC, Athienites NV, Yan G, Martin AA, Ornt DB, Kusek JW, et al. Comorbidity assessment using the Index of Coexistent Diseases in a multicenter clinical trial. Kidney Int 2001; 60: 1498-1510.
10. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612.
11. Stevens LA, Schmid CH, Greene T, Zhang YL, Beck GJ, Froissart M, et al. Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/ min/1.73 m2. Am J Kidney Dis 2010; 56: 486-495.
12. Schmoor C, Sauerbrei W, Schumacher M. Sample size considerations for the evaluation of prognostic factors in survival analysis. Stat Med 2000; 19: 441-452.
13. The Nephrology Society of Thailand: Thailand Renal Replacement Therapy Year 2008. Bangkok 2010.
14. Lin X, Yan Y, Ni Z, Gu L, Zhu M, Dai H, et al. Clinical outcome of twice-weekly hemodialysis patients in shanghai. Blood Purif 2012; 33: 66-72.
15. USRDS 2012 Annual Report: National Institute of Diabetes and Digestive and Kidney Diseases. Bethesda, MD, 2012.
16. Goodkin DA, Bragg-Gresham JL, Koenig KG, Wolfe RA, Akiba T, Andreucci VE, et al. Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol 2003; 14: 3270-3277.
17. Cheng X, Nayyar S, Wang M, Li X, Sun Y, Huang W, et al. Mortality rates among prevalent hemodialysis patients in Beijing: a comparison with USRDS data. Nephrol Dial Transplant 2013; 28: 724-732.
18. Amaral S, Hwang W, Fivush B, Neu A, Frankenfield D, Furth S. Serum albumin level and risk for mortality and hospitalization in adolescents on hemodialysis. Clin J Am Soc Nephrol 2008; 3: 759-767.
19. Combe C, McCullough KP, Asano Y, Ginsberg N, Maroni BJ, Pifer TB. Kidney Disease Outcomes Quality Initiative (K/DOQI) and the Dialysis Outcomes and Practice Patterns Study (DOPPS): nutrition guidelines, indicators, and practices. Am J Kidney Dis 2004;44(5 suppl 2):39-46.
20. de Mutsert R, Grootendorst DC, Indemans F, Boeschoten EW, Krediet RT, Dekker FW. Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition. J Ren Nutr 2009; 19: 127-135.
21. Cooper BA, Penne EL, Bartlett LH, Pollock CA. Protein malnutrition and hypoalbuminemia as predictors of vascular events and mortality in ESRD. Am J Kidney Dis 2004; 43: 61-66.
22. Foley RN, Herzog CA, Collins AJ. Smoking and cardiovascular outcomes in dialysis patients: the United States Renal Data System Wave 2 study. Kidney Int 2003; 63: 1462-1467.
23. Biesenbach G, Zazgornik J. Influence of smoking on the survival rate of diabetic patients requiring hemodialysis. Diabetes Care 1996; 19: 625-628.
24. Liebman SE, Lamontagne SP, Huang LS, Messing S, Bushinsky DA. Smoking in dialysis patients: a systematic review and metaanalysis of mortality and cardiovascular morbidity. Am J Kidney Dis 2011; 58: 257-265.
25. K/DOQI Workgroup: K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 2005; 45(4 suppl 3):S1-S153.
26. Vilar E, Wellsted D, Chandna SM, Greenwood RN, Farrington K. Residual renal function improves outcome in incremental haemodialysis despite reduced dialysis dose. Nephrol Dial Transplant 2009; 24: 2502-2510.
27. Shafi T, Jaar BG, Plantinga LC, Fink NE, Sadler JH, Parekh RS, et al. Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study. Am J Kidney Dis 2010; 56: 348-358.